|
1
|
Kubo S, Mimaki Y, Terao M, Sashida Y,
Nikaido T and Ohmoto T: Acylated cholestane glycosides from the
bulbs of Ornithogalum saudersiae. Phytochemistry.
31:3969–3973. 1992. View Article : Google Scholar
|
|
2
|
Mimaki Y, Kuroda M, Kameyama A, Sashida Y,
Hirano T and Oka K: Cholestane glycosides with potent cytostatic
activities on various tumor cells from Ornithogalum
saundersiae bulls. Bioorg Med Chem Lett. 7:633–636. 1997.
View Article : Google Scholar
|
|
3
|
Zhou Y, Garcia-Prieto C, Carney DA, et al:
OSW-1: a natural compound with potent anticancer activity and a
novel mechanism of action. J Natl Cancer Inst. 97:1781–1785. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai FG, Xiao JS and Ye QF: Effects of
ischemic preconditioning on cyclinD1 expression during early
ischemic reperfusion in rats. World J Gastroenterol. 12:2936–2940.
2006.PubMed/NCBI
|
|
5
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McKay MM and Morrison DK: Integrating
signals from RTKs to ERK/MAPK. Oncogene. 26:3113–3121. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ballif BA and Blenis J: Molecular
mechanisms mediating mammalian mitogen-activated protein kinase
(MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ.
12:397–408. 2001.PubMed/NCBI
|
|
8
|
Bonni A, Brunet A, West AE, Datta SR,
Takasu MA and Greenberg ME: Cell survival promoted by the Ras-MAPK
signalling pathway by transcription-dependent and -independent
mechanisms. Science. 286:1358–1362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J, Xiong L, Yu B and Wu J: Apoptosis
induced by a new member of saponin family is mediated through
caspase-8-dependent cleavage of Bcl-2. Mol Pharmacol. 68:1831–1838.
2005.PubMed/NCBI
|
|
10
|
Porras A, Zuluaga S, Black E, et al: P38
alpha mitogen-activated protein kinase sensitizes cells to
apoptosis induced by different stimuli. Mol Biol Cell. 15:922–933.
2004. View Article : Google Scholar
|
|
11
|
Grethe S and Pörn-Ares MI: p38 MAPK
regulates phosphorylation of Bad via PP2A-dependent suppression of
the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial
apoptosis. Cell Signal. 18:531–540. 2006. View Article : Google Scholar
|
|
12
|
Zhong Q, Zhou Y, Ye W, Cai T, Zhang X and
Deng DY: Hypoxia-inducible factor 1-α-AA-modified bone marrow stem
cells protect PC12 cells from hypoxia-induced apoptosis, partially
through VEGF/PI3K/Akt/FoxO1 pathway. Stem Cells Dev. 21:2703–2717.
2012.
|
|
13
|
Adya R, Tan BK, Punn A, Chen J and Randeva
HS: Visfatin induces human endothelial VEGF and MMP-2/9 production
via MAPK and PI3K/Akt signalling pathways: novel insights into
visfatin-induced angiogenesis. Cardiovasc Res. 78:356–365. 2008.
View Article : Google Scholar
|
|
14
|
Chiang IT, Liu YC, Wang WH, et al:
Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via
suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
In Vivo. 26:671–681. 2012.PubMed/NCBI
|
|
15
|
Villunger A, Michalak EM, Coultas L, et
al: p53- and drug-induced apoptotic responses mediated by BH3-only
proteins puma and noxa. Science. 302:1036–1038. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park SY, Jeong MS and Jang SB: In vitro
binding properties of tumor suppressor p53 with PUMA and NOXA.
Biochem Biophys Res Commun. 420:350–356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang DC and Strasser A: BH3-only proteins
- essential initiators of apoptotic cell death. Cell. 103:839–842.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michalak EM, Villunger A, Adams JM and
Strasser A: In several cell types tumour suppressor p53 induces
apoptosis largely via Puma but Noxa can contribute. Cell Death
Differ. 15:1019–1029. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vaseva AV and Moll UM: The mitochondrial
p53 pathway. Biochim Biophys Acta. 1787:414–420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leu JI, Dumont P, Hafey M, Murphy ME and
George DL: Mitochondrial p53 activates Bak and causes disruption of
a Bak-Mcl1 complex. Nat Cell Biol. 6:443–450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gogvadze V, Orrenius S and Zhivotovsky B:
Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol.
19:57–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagata S and Golstein P: The Fas death
factor. Science. 267:1449–1456. 1995. View Article : Google Scholar
|
|
23
|
O’Connor L, Harris AW and Strasser A: CD95
(Fas/APO-1) and p53 signal apoptosis independently in diverse cell
types. Cancer Res. 60:1217–1220. 2000.PubMed/NCBI
|
|
24
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: an ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han W, Li L, Qiu S, et al: Shikonin
circumvents cancer drug resistance by induction of a necroptotic
death. Mol Cancer Ther. 6:1641–1649. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Burgett AW, Poulsen TB, Wangkanont K, et
al: Natural products reveal cancer cell dependence on
oxysterol-binding proteins. Nat Chem Biol. 7:639–647. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hitomi J, Christofferson DE, Ng A, Yao J,
Degterev A, Xavier RJ and Yuan J: Identification of a molecular
signalling network that regulates a cellular necrotic cell death
pathway. Cell. 135:1311–1323. 2008. View Article : Google Scholar : PubMed/NCBI
|
